Bipolar Disorder Nursing Guide

Definition & Classification

Bipolar disorder is a chronic mood disorder characterised by episodic periods of mania/hypomania and depression, with periods of normal mood (euthymia) in between. It affects approximately 1–2% of the population worldwide.

DSM-5 Classification

Type	Episodes	Key Difference
Bipolar I	≥1 manic episode (with or without depressive episodes)	Full mania ≥7 days OR requiring hospitalisation; psychosis may occur
Bipolar II	≥1 hypomanic + ≥1 major depressive episode	Hypomania (4–6 days, less severe than mania); no psychosis
Cyclothymia	Chronic fluctuating hypo/depressive symptoms >2 years	Symptoms below threshold for full episode diagnosis

Key distinction — Mania vs Hypomania: Mania lasts ≥7 days (or requires hospitalisation), significantly impairs function, may include psychosis. Hypomania lasts 4–6 days, is noticeable but does NOT cause marked impairment or require hospitalisation, with NO psychosis.

Aetiology & Risk Factors

Biological

Genetic: heritability ~60–80% (first-degree relative increases risk 10×)
Neurotransmitter dysregulation (dopamine, serotonin, noradrenaline)
Circadian rhythm disruption
HPA axis dysregulation (stress response)

Environmental Triggers

Sleep deprivation (major trigger for mania)
Life stressors, bereavement, significant events
Substance use (cannabis, stimulants, alcohol)
Antidepressants without mood stabiliser (can trigger mania)
Seasonal changes (light exposure)

Clinical Features Comparison

☀️ Manic Episode

Elevated/irritable mood ≥7 days

Grandiosity, inflated self-esteem
Decreased need for sleep (not tired after 3 hrs)
Pressured/rapid speech (talkativeness)
Flight of ideas, racing thoughts
Distractibility
Increased goal-directed activity
Risky behaviours (spending, sex, substances)
Psychosis (delusions, hallucinations) — Bipolar I

🌑 Depressive Episode

Depressed mood ≥2 weeks (5+ symptoms)

Persistent low mood
Anhedonia (loss of pleasure)
Changes in sleep (insomnia or hypersomnia)
Fatigue, loss of energy
Psychomotor agitation or retardation
Poor concentration
Feelings of worthlessness, guilt
Suicidal ideation (HIGH RISK)

Suicide risk in Bipolar Disorder: Lifetime suicide risk is 15–20x higher than general population. Assess suicide risk at every contact, especially during depressive phase, mixed states, and after a manic episode (post-manic depression).

Mixed States

Mixed features = simultaneous manic and depressive symptoms. Associated with highest suicide risk. Patient may have racing thoughts (mania) + hopelessness (depression) simultaneously — particularly dangerous combination as the patient has "energy" to act on suicidal thoughts.

Mnemonic — Manic Episode: DIG FAST

Letter	Feature
D	Distractibility
I	Impulsivity / Irresponsible behaviours
G	Grandiosity
F	Flight of ideas
A	Activity increased (goal-directed)
S	Sleep decreased (no fatigue despite minimal sleep)
T	Talkativeness (pressured speech)

3 or more of DIG FAST criteria (with elevated/irritable mood ≥7 days causing impairment) = manic episode.

Lithium — The Gold Standard Mood Stabiliser

Lithium is the most effective prophylactic treatment for bipolar disorder and reduces suicide risk. However, it has a narrow therapeutic index — regular blood level monitoring is essential.

Lithium Therapeutic Levels

Indication	Target Level (12-hour trough)
Acute mania treatment	0.8–1.2 mmol/L
Maintenance / prophylaxis	0.6–0.8 mmol/L
Elderly patients	0.4–0.6 mmol/L (lower to reduce toxicity)

Blood sampling: Lithium levels must be taken 12 hours after the last dose (trough level). Levels taken at other times are meaningless. Frequency: weekly until stable, then every 3–6 months.

Lithium Toxicity — Levels & Features

Mild Toxicity (1.5–2.0 mmol/L)

Nausea, vomiting, diarrhoea
Coarse tremor (fine tremor is normal at therapeutic levels)
Thirst, polyuria
Mild drowsiness

Moderate Toxicity (2.0–2.5 mmol/L)

Confusion, drowsiness, ataxia
Slurred speech, muscle twitching
ECG changes (T wave flattening, QT prolongation)

Severe Toxicity (>2.5 mmol/L) — Medical Emergency

Seizures, coma
Cardiac arrhythmias
Renal failure
Treatment: haemodialysis

Factors That Increase Lithium Levels (Toxicity Risk)

Dehydration — vomiting, diarrhoea, excessive sweating (very relevant in GCC summers)
Low sodium diet — Ramadan dietary changes, salt-restricted diets
NSAIDs — reduce renal lithium clearance (ibuprofen, diclofenac)
ACE inhibitors / ARBs — reduce renal clearance
Thiazide diuretics
Renal impairment

Lithium Monitoring Schedule

Test	Frequency
Serum lithium level	Weekly until stable; every 3–6 months maintenance
Renal function (U&E, eGFR)	Every 6 months (lithium is nephrotoxic long-term)
Thyroid function (TSH)	Every 6 months (lithium causes hypothyroidism in up to 40%)
Calcium	Annually (lithium can cause hypercalcaemia)
ECG (baseline)	Before starting; if cardiac risk

Other Mood Stabilisers

Drug	Use	Key Monitoring / Concerns
Valproate (sodium valproate)	Acute mania, prophylaxis (especially rapid cycling)	TERATOGENIC — avoid in women of childbearing age; liver function; platelets; pancreatitis risk
Lamotrigine	Bipolar depression prevention (not acute mania)	Stevens-Johnson syndrome (SJS) risk — slow titration essential; never rapid dose increase
Quetiapine (atypical antipsychotic)	Acute mania AND bipolar depression	Metabolic syndrome, weight gain, postural hypotension, QTc prolongation
Olanzapine	Acute mania, agitation	Significant weight gain, metabolic syndrome, diabetes risk
Haloperidol	Acute mania with psychosis	EPS (extrapyramidal side effects), NMS risk

Valproate + women of childbearing potential: Sodium valproate causes neural tube defects (spina bifida) in up to 10% of pregnancies. In the GCC, valproate is subject to the same PREVENT programme restrictions as in the UK. All female patients must be on effective contraception and counselled annually about risks.

Nursing Management — Acute Manic Episode

Environment & Safety

Low-stimulation environment — reduce noise, bright lights, visitors, TV/phone overstimulation
Set clear, consistent limits on unacceptable behaviour — firm but non-confrontational approach
Ensure a safe environment — remove access to means of financial risk, sharp objects if needed
Monitor for impulsive, risky behaviour (spending, sexual disinhibition)
Observation levels: regular 15–30 minute checks or 1:1 if high risk

Communication — De-escalation Principles

Speak calmly, slowly, in a low tone — match their pace gently; do not shout or argue
Avoid prolonged engagement with grandiose ideation — briefly acknowledge, redirect
Use short, clear sentences — manic patients have poor concentration
Acknowledge distress without reinforcing delusions
Allow controlled space/movement if safe — pacing is normal; forced immobility increases agitation
Involve a familiar trusted staff member or family (if appropriate in GCC context)

Physical Care

Nutrition — provide high-calorie, easy-to-eat foods; manic patients may not stop to eat; "finger foods" approach
Hydration — ensure adequate fluid intake (critical for lithium patients in GCC heat)
Sleep promotion — sleep hygiene, reduce caffeine, consistent routine; sleep deprivation perpetuates mania
Medication administration — ensure compliance; IM preparations may be needed acutely (haloperidol, lorazepam, olanzapine)

Nursing Management — Depressive Phase

Suicide risk assessment — validated tools (Columbia Suicide Severity Rating Scale); ask directly about suicidal ideation, plan, intent, access to means
Close observations — 15-minute or 1:1 if high suicide risk; remove ligature risks
Therapeutic relationship — regular named nurse contact; non-judgmental listening
Encourage gentle activity, sleep hygiene, regular meals
Monitor for medication adherence
Psychoeducation — explain this phase is temporary; support hope
Family education — recognise warning signs of relapse

Antidepressants alone are contraindicated in bipolar disorder without a concurrent mood stabiliser — they can trigger a manic switch. Always ensure a mood stabiliser is in place before any antidepressant.

GCC-Specific Considerations

Stigma & Help-Seeking in GCC Culture ▼

Mental illness carries significant stigma in GCC societies. Patients and families may attribute bipolar symptoms to supernatural causes (jinn, evil eye/ayn) or spiritual weakness. Nurses should provide culturally sensitive education, involve religious and family support structures where appropriate, and work within the patient's cultural framework without dismissing religious beliefs. Many GCC countries have invested heavily in reducing mental health stigma (e.g., Saudi Arabia's Vision 2030 mental health initiatives).

Lithium & Ramadan Fasting ▼

Lithium dosing during Ramadan requires careful management. Fasting reduces fluid intake during daylight hours and dramatically increases dehydration risk, especially in hot GCC summers. Dehydration increases lithium reabsorption and risks toxicity. Advise patients to: (1) maintain adequate fluid intake at Suhoor and Iftar, (2) check lithium levels before and during Ramadan, (3) consider dose timing adjustments with psychiatric team, (4) avoid NSAIDs during fasting. Some patients may need temporary dose reduction.

Heat, Sweating & Lithium Toxicity ▼

GCC summer temperatures exceed 45°C. Excessive sweating causes sodium and fluid depletion, which reduces renal lithium clearance — increasing lithium levels. Patients on lithium must be educated to stay hydrated, avoid prolonged outdoor exposure in summer, maintain adequate salt intake (low-sodium diets increase lithium reabsorption), and seek medical review if they develop diarrhoea, vomiting, or febrile illness.

Family Involvement & Collectivist Decision-Making ▼

GCC cultures are predominantly collectivist — family involvement in healthcare decisions is expected and valued. In bipolar management, family psychoeducation is crucial: recognising early warning signs of mania or depression, preventing medication non-compliance, and supporting recovery. Male family members (wali/guardian) may be involved in consent and discharge decisions for female patients. Nurses should navigate these dynamics while respecting patient autonomy within institutional guidelines.

Substance Use & Bipolar Comorbidity ▼

While alcohol use is less common in GCC Muslim populations, khat (qat) chewing is prevalent among East African and Yemeni communities in some GCC countries and is a stimulant that can trigger mania. Cannabis use is also documented among younger GCC residents and can worsen bipolar instability. Nurses should include substance use screening in all bipolar assessments without cultural judgment.

MCQ Practice — Bipolar Disorder

Q1. A patient on lithium presents with coarse tremor, confusion, ataxia, and slurred speech. Their lithium level is 2.2 mmol/L. What is the appropriate management?

A) Continue lithium at the same dose and recheck level in 1 week

B) Reduce lithium dose by 50% and monitor closely

C) Stop lithium, ensure IV hydration, monitor renal function, consider haemodialysis if worsening

D) Give activated charcoal and continue lithium at lower dose

✅ C — Lithium level 2.2 mmol/L with neurological symptoms = moderate-severe toxicity. Lithium must be stopped immediately. IV fluids support renal clearance. Haemodialysis is the definitive treatment for severe toxicity (>2.5 mmol/L) or worsening symptoms.

Q2. A nurse is educating a patient on lithium about risks during Ramadan fasting. Which instruction is MOST important?

A) Stop lithium during Ramadan to avoid toxicity

B) Take ibuprofen for any pain rather than paracetamol during Ramadan

C) Maintain adequate fluid and salt intake at Suhoor and Iftar, and have lithium levels checked

D) Switch to valproate during Ramadan as it is safer

✅ C — Dehydration and low sodium (from fasting/sweating) reduce renal lithium clearance, increasing toxicity risk. Adequate fluids and salt intake are critical. NSAIDs (ibuprofen) are contraindicated as they also reduce lithium clearance. Never stop lithium abruptly — risk of rebound mania.

Q3. Which mood stabiliser is CONTRAINDICATED in women of childbearing age without highly effective contraception due to teratogenicity?

A) Lithium

B) Lamotrigine

C) Sodium valproate

D) Quetiapine

✅ C — Sodium valproate causes neural tube defects (spina bifida) in up to 10% of exposed pregnancies and is associated with autism spectrum disorder and developmental delay in children. It is subject to strict pregnancy prevention programmes. All female patients must be on effective contraception.

Q4. A patient in an acute manic episode is pacing, talking rapidly, and becoming increasingly agitated. Which nursing approach is MOST appropriate?

A) Firmly confront their grandiose beliefs to re-orient them to reality

B) Physically restrain the patient to prevent injury

C) Increase environmental stimulation with TV and social interaction to distract them

D) Speak calmly, provide low-stimulation environment, and redirect with short clear statements

✅ D — De-escalation in mania involves a calm, non-confrontational approach, low stimulation, short clear sentences, and gentle redirection. Confronting grandiosity increases agitation. Physical restraint should only be a last resort when risk of harm is imminent. High stimulation worsens mania.

Bipolar Disorder — Nursing Guide